EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma

BACKGROUND: It is urgent to explore an effective potential therapeutic strategy for ESCC. In recent years, cell-based cancer immunotherapy has become a potentially close for carcinoma therapy. Chimeric antigen receptor (CAR) T cell technology is a kind of adoptive cell therapy technique which has be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Thorac Dis
Hauptverfasser: Shi, Hui, Yu, Feng, Mao, Yinting, Ju, Qianqian, Wu, Yingcheng, Bai, Wen, Wang, Peiwen, Xu, Ran, Jiang, Maorong, Shi, Jiahai
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2018
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006048/
https://ncbi.nlm.nih.gov/pubmed/29997940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.04.91
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge